These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 10604117)

  • 1. Molecular aspects of the endocrine tumours of the pancreas and the gastrointestinal tract.
    Rindi G; Candusso ME; Solcia E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S135-8. PubMed ID: 10604117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
    Rindi G; Bordi C
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):519-34. PubMed ID: 16183525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.
    Pizzi S; D'Adda T; Azzoni C; Rindi G; Grigolato P; Pasquali C; Corleto VD; Delle Fave G; Bordi C
    J Pathol; 2002 Apr; 196(4):401-7. PubMed ID: 11920735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour biology and histopathology of neuroendocrine tumours.
    Klöppel G
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
    Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B
    Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
    Rindi G; Villanacci V; Ubiali A
    Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
    Arnold R
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
    Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
    Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gastroenteropancreatic endocrine system and related tumors.
    Solcia E; Capella C; Fiocca R; Cornaggia M; Bosi F
    Gastroenterol Clin North Am; 1989 Dec; 18(4):671-93. PubMed ID: 2575601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas.
    Jakobsen AM; Ahlman H; Wängberg B; Kölby L; Bengtsson M; Nilsson O
    J Pathol; 2002 Jan; 196(1):44-50. PubMed ID: 11748641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highlights of the biology of endocrine tumours of the gut and pancreas.
    Rindi G; Bordi C
    Endocr Relat Cancer; 2003 Dec; 10(4):427-36. PubMed ID: 14713255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of H-ras and K-ras in tumors of gastrointestinal-pancreatic system].
    Liedke M; Karnbach C; Kalinin V; Herbst B; Frilling A; Broelsch CE
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):255-9. PubMed ID: 14518255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coexistence of two different neuroendocrine tumors of the upper gastrointestinal tract and of the pancreas].
    Ritter MR; Höppner W
    Dtsch Med Wochenschr; 1999 Jun; 124(22):712; discussion 713. PubMed ID: 10394354
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of sporadic pancreatic endocrine tumours.
    Perren A; Roth J; Muletta-Feurer S; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
    J Pathol; 1998 Dec; 186(4):363-71. PubMed ID: 10209484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract.
    Pizzi S; Azzoni C; Bassi D; Bottarelli L; Milione M; Bordi C
    Cancer; 2003 Sep; 98(6):1273-82. PubMed ID: 12973852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
    Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
    Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroenteropancreatic endocrine tumors.
    Meeker A; Heaphy C
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.